Neurologic complications of chemotherapy agents
@article{Kannarkat2007NeurologicCO, title={Neurologic complications of chemotherapy agents}, author={George Kannarkat and Erin E. Lasher and David Schiff}, journal={Current Opinion in Neurology}, year={2007}, volume={20}, pages={719–725} }
Purpose of reviewTo review neurologic complications of common and recently developed chemotherapeutic agents, as well as recent research regarding ‘chemobrain’. Recent findingsBortezomib, a new anticancer agent, has a propensity toward causing a largely sensory and reversible peripheral neuropathy. Infusion of magnesium and calcium pre and post-oxaliplatin infusion reduces neuropathy but may interfere with clinical response to oxaliplatin. No other measures currently reduce the incidence or…
175 Citations
Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
- Biology, MedicineThe Netherlands journal of medicine
- 2012
Several neuroprotective strategies have been investigated to decrease the neurotoxicity without compromising anti-tumour efficacy, with calcium/magnesium infusion, amifostine, gluthatione, glutamine, acetyl-L-carnitine and erythropoietin as most promising.
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
- BiologyEuropean journal of cancer
- 2008
Animal models of chemotherapy-evoked painful peripheral neuropathies
- Medicine, BiologyNeurotherapeutics
- 2011
Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- Medicine, Biology
- 2018
The authors analyze the potential applications of nutrients, dietary supplements and herbal products, such as single herbs, the Kampo medicine goshajinkigan and other herbal combinations, for CIPN prevention.
Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy
- Biology
- 2014
The characterization of this animal model of chemotherapy-induced peripheral neuropathy suggests that the neurochemical changes occurring in populations of DRG neurons that are likely involved in pain transmission appear to be an important component of the sensory neuropathy induced by the bortezomib-treatment and may represent the outcome of the molecular machine activated by the drug during the onset and persistence of bortzomib -induced neuropathic pain.
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
- BiologyExpert review of hematology
- 2020
This review has examined some commonly used drugs for the treatment of hematological malignancies which are known to have a deleterious action on cognitive functions and the interactions between genetic risk, amyloid accumulation, intrinsic brain networks, and chemotherapy.
An Overview of Chemotherapy-Induced Peripheral Neuropathy
- Medicine, Biology
- 2008
Peripheral neuropathy remains a major limitation of chemotherapeutic agents used in cancer treatment and prompt recognition and evaluation by those who provide care to patients with cancer can prove to have a positive impact on the quality of life of those patients.
References
SHOWING 1-10 OF 52 REFERENCES
Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
- Biology, PsychologySeminars in clinical neuropsychiatry
- 2003
Large-scale prospective studies are needed to help isolate the pathophysiological mechanisms underlying the cognitive deficits associated with chemotherapy, and studies of other brain disorders or treatment effects that might serve as a model for imaging chemotherapy-induced changes are noted.
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
- MedicineInvestigational New Drugs
- 2006
Based on the small number of patients and low statistical power of the study definite conclusions regarding efficacy and safety of carbamazepine for prevention of oxaliplatin-associated neuropathy in patients with advanced colorectal cancer cannot be drawn.
[Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
- Medicine, BiologyGan to kagaku ryoho. Cancer & chemotherapy
- 2007
Ca/Mg infusions seem to prevent acute oxaliplatin-induced neurotoxic in patients with metastatic colorectal cancer and there was no neurotoxicity with functional impairment in this study.
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
- Medicine, BiologyClinical Cancer Research
- 2004
Ca/Mg infusions seem to reduce incidence and intensity of acute oxaliplatin-induced symptoms and might delay cumulative neuropathy, especially in 85 mg/m2 oxali Platin dosage.
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
- Biology, MedicineJournal of biology
- 2006
Identifying neural populations at risk during any cancer treatment is of great importance in developing means of reducing neurotoxicity and preserving quality of life in long-term survivors, and the strong correlations between in vitro and in vivo analyses indicate that the same approaches used to identify the reported toxicities can also provide rapid in vitro screens for analyzing new therapies and discovering means of achieving selective protection or targeted killing.
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.
- BiologyJournal of neurophysiology
- 2001
Oxaliplatin, a new widely used anticancer drug, displays frequent, sometimes severe, acute sensory neurotoxicity accompanied by neuromuscular signs that look like the symptoms observed in tetany and…
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
- Medicine, PsychologyJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
Bortezomib-associated peripheral neuropathy seemed reversible in the majority of patients after dose reduction or discontinuation, and the overall occurrence was independent of baseline neuropathy or type of prior therapy.
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
- Biology, MedicineExperimental Neurology
- 2007
Candidate mechanisms for chemotherapy-induced cognitive changes
- Biology, PsychologyNature Reviews Cancer
- 2007
It is suggested that shared genetic risk factors for the development of cancer and cognitive problems, including low-efficiency efflux pumps, deficits in DNA-repair mechanisms and/or a deregulated immune response, coupled with the effect of chemotherapy on these systems, might contribute to cognitive decline in patients after chemotherapy.
Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
- MedicineJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2007